LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 65

Search options

  1. Article ; Online: Applications of next-generation sequencing in hematologic malignancies.

    Ramkissoon, Lori A / Montgomery, Nathan D

    Human immunology

    2021  Volume 82, Issue 11, Page(s) 859–870

    Abstract: In the last decade, next-generation sequencing (NGS) has rapidly progressed from a research method to a core component of standard-of-care clinical testing. In oncology, tumor sequencing provides a critical tool to detect somatic driver mutations that ... ...

    Abstract In the last decade, next-generation sequencing (NGS) has rapidly progressed from a research method to a core component of standard-of-care clinical testing. In oncology, tumor sequencing provides a critical tool to detect somatic driver mutations that not only characterize disease but also impact therapeutic decision-making. Here, we review the important role of NGS in the evaluation of hematopoietic neoplasms. We discusstechnical and practical considerations relevant in somatic mutation testing, emphasizing issues unique to blood cancers. Then, we describe how NGS data is being used to facilitate diagnosis, inform prognosis, guide therapy selection, and even monitor disease. This broad overview highlights the transformative impacts NGS data provides throughout the clinical course of patients with hematologic malignancies.
    MeSH term(s) Biomarkers, Tumor/genetics ; DNA Mutational Analysis/methods ; Hematologic Neoplasms/diagnosis ; Hematologic Neoplasms/genetics ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/therapy ; High-Throughput Nucleotide Sequencing ; Humans ; Mutation ; Precision Medicine/methods ; Prognosis ; Risk Assessment/methods
    Chemical Substances Biomarkers, Tumor
    Language English
    Publishing date 2021-02-27
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 801524-7
    ISSN 1879-1166 ; 0198-8859
    ISSN (online) 1879-1166
    ISSN 0198-8859
    DOI 10.1016/j.humimm.2021.02.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report.

    Kumar, Vaibhav / Montgomery, Nathan D / van Deventer, Hendrik W / Whang, Young E

    Journal of medical case reports

    2023  Volume 17, Issue 1, Page(s) 220

    Abstract: Background: Hypoproliferative anemia is a frequently encountered adverse event in cancer patients receiving immune checkpoint inhibitors (ICI). Secondary pure red cell aplasia (PRCA) is a rare but recognized immune related adverse event. With the ... ...

    Abstract Background: Hypoproliferative anemia is a frequently encountered adverse event in cancer patients receiving immune checkpoint inhibitors (ICI). Secondary pure red cell aplasia (PRCA) is a rare but recognized immune related adverse event. With the burgeoning use of ICIs, the association of secondary PRCA with an underlying lymphoproliferative disorder is often overlooked.
    Case presentation: We report a case of a 67-year-old non-Hispanic Caucasian male with metastatic castrate resistant prostate cancer, who developed severe transfusion dependent anemia with reticulocytopenia while receiving treatment with olaparib and pembrolizumab. His bone marrow findings demonstrated erythroid hypoplasia, in addition to a CD5-negative, CD10-negative monotypic B-cell population and a somatic MYD88L265P mutation. With a presence of an IgM-paraprotein, he was diagnosed with Waldenström macroglobulinemia (WM) with secondary PRCA and treated with 6 cycles of bendamustine and rituximab. He achieved a complete response with this regimen and was transfusion independent.
    Conclusion: In this case, underlying WM was uncovered through systematic investigation of anemia caused by ICI therapy. This report highlights the possibility of a lymphoproliferative disorder in patients with concerns for PRCA with prior ICI exposure. If identified, treating the underlying lymphoproliferative disorder is highly efficacious in the management of the secondary PRCA.
    MeSH term(s) Humans ; Male ; Aged ; Immune Checkpoint Inhibitors ; Waldenstrom Macroglobulinemia/complications ; Waldenstrom Macroglobulinemia/drug therapy ; Red-Cell Aplasia, Pure/chemically induced ; Red-Cell Aplasia, Pure/drug therapy ; Red-Cell Aplasia, Pure/complications ; Anemia/chemically induced ; Prostatic Neoplasms/complications ; Lymphoproliferative Disorders
    Chemical Substances Immune Checkpoint Inhibitors
    Language English
    Publishing date 2023-05-28
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 2269805-X
    ISSN 1752-1947 ; 1752-1947
    ISSN (online) 1752-1947
    ISSN 1752-1947
    DOI 10.1186/s13256-023-03948-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assay.

    Raval, Jay S / Montgomery, Nathan D / Rollins-Raval, Marian A

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

    2021  Volume 32, Issue 4, Page(s) 302–303

    MeSH term(s) Antibodies/immunology ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Anticoagulants/blood ; Drug Monitoring ; Enzyme-Linked Immunosorbent Assay/methods ; Heparin/administration & dosage ; Heparin/adverse effects ; Heparin/blood ; Humans ; Immunoglobulin G/immunology ; Platelet Factor 4/immunology ; Thrombocytopenia/chemically induced ; Thrombocytopenia/diagnosis ; Thrombocytopenia/immunology
    Chemical Substances Antibodies ; Anticoagulants ; Immunoglobulin G ; Platelet Factor 4 (37270-94-3) ; Heparin (9005-49-6)
    Language English
    Publishing date 2021-05-06
    Publishing country England
    Document type Letter
    ZDB-ID 1033551-1
    ISSN 1473-5733 ; 0957-5235
    ISSN (online) 1473-5733
    ISSN 0957-5235
    DOI 10.1097/MBC.0000000000001034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.

    Jensen, Christopher E / Montgomery, Nathan D / Galeotti, Jonathan / Foster, Matthew C / Zeidner, Joshua F

    Journal of cellular and molecular medicine

    2022  

    Language English
    Publishing date 2022-11-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2074559-X
    ISSN 1582-4934 ; 1582-4934 ; 1582-1838
    ISSN (online) 1582-4934
    ISSN 1582-4934 ; 1582-1838
    DOI 10.1111/jcmm.17608
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Advancing Global Health Surveillance of Mycotoxin Exposures using Minimally Invasive Sampling Techniques: A State-of-the-Science Review.

    Jacobson, Tyler A / Bae, Yeunook / Kler, Jasdeep S / Iyer, Ramsunder / Zhang, Runze / Montgomery, Nathan D / Nunes, Denise / Pleil, Joachim D / Funk, William E

    Environmental science & technology

    2024  Volume 58, Issue 8, Page(s) 3580–3594

    Abstract: Mycotoxins are a heterogeneous group of toxins produced by fungi that can grow in staple crops (e.g., maize, cereals), resulting in health risks due to widespread exposure from human consumption and inhalation. Dried blood spot (DBS), dried serum spot ( ... ...

    Abstract Mycotoxins are a heterogeneous group of toxins produced by fungi that can grow in staple crops (e.g., maize, cereals), resulting in health risks due to widespread exposure from human consumption and inhalation. Dried blood spot (DBS), dried serum spot (DSS), and volumetric tip microsampling (VTS) assays were developed and validated for several important mycotoxins. This review summarizes studies that have developed these assays to monitor mycotoxin exposures in human biological samples and highlights future directions to facilitate minimally invasive sampling techniques as global public health tools. A systematic search of PubMed (MEDLINE), Embase (Elsevier), and CINAHL (EBSCO) was conducted. Key assay performance metrics were extracted to provide a critical review of the available methods. This search identified 11 published reports related to measuring mycotoxins (ochratoxins, aflatoxins, and fumonisins) using DBS/DSS and VTS assays. Multimycotoxin assays adapted for DBS/DSS and VTS have undergone sufficient laboratory validation for applications in large-scale population health and human biomonitoring studies. Future work should expand the number of mycotoxins that can be measured in multimycotoxin assays, continue to improve multimycotoxin assay sensitivities of several biomarkers with low detection rates, and validate multimycotoxin assays across diverse populations with varying exposure levels. Validated low-cost and ultrasensitive minimally invasive sampling methods should be deployed in human biomonitoring and public health surveillance studies to guide policy interventions to reduce inequities in global mycotoxin exposures.
    MeSH term(s) Humans ; Mycotoxins/analysis ; Global Health ; Trichothecenes/analysis ; Aflatoxins ; Ochratoxins/analysis ; Food Contamination
    Chemical Substances Mycotoxins ; Trichothecenes ; Aflatoxins ; Ochratoxins
    Language English
    Publishing date 2024-02-14
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 1520-5851
    ISSN (online) 1520-5851
    DOI 10.1021/acs.est.3c04981
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Comprehensive genomic profiling reveals molecular subsets of

    Johnson, Steven M / Haberberger, James / Galeotti, Jonathan / Ramkissoon, Lori / Coombs, Catherine C / Richardson, Daniel R / Foster, Matthew C / Duncan, Daniel / Montgomery, Nathan D / Ferguson, Naomi L / Zeidner, Joshua F

    Leukemia & lymphoma

    2024  Volume 65, Issue 2, Page(s) 209–218

    Abstract: A large-scale genomic analysis of patients ... ...

    Abstract A large-scale genomic analysis of patients with
    MeSH term(s) Adult ; Humans ; Myeloproliferative Disorders/genetics ; Spliceosomes/genetics ; Spliceosomes/pathology ; Transcription Factors/genetics ; Neoplasms ; Genomics ; Mutation ; Leukemia, Myeloid, Acute/genetics ; Prognosis ; Repressor Proteins/genetics
    Chemical Substances Transcription Factors ; ASXL1 protein, human ; Repressor Proteins
    Language English
    Publishing date 2024-01-24
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 1042374-6
    ISSN 1029-2403 ; 1042-8194
    ISSN (online) 1029-2403
    ISSN 1042-8194
    DOI 10.1080/10428194.2023.2277672
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Transformation in Low-grade B-cell Neoplasms.

    Montgomery, Nathan D / Mathews, Stephanie P

    Surgical pathology clinics

    2016  Volume 9, Issue 1, Page(s) 79–92

    Abstract: Low-grade B-cell leukemias/lymphomas are a diverse group of indolent lymphoproliferative disorders that are typically characterized by good patient outcomes and long life expectancies. A subset of cases, however, undergo histologic transformation to a ... ...

    Abstract Low-grade B-cell leukemias/lymphomas are a diverse group of indolent lymphoproliferative disorders that are typically characterized by good patient outcomes and long life expectancies. A subset of cases, however, undergo histologic transformation to a higher-grade neoplasm, a transition associated with a more aggressive clinical course and poor survival. Transformation of follicular lymphoma to diffuse large B-cell lymphoma and Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma are best characterized in the literature. This article reviews clinical and pathologic characteristics of these most common forms of transformation, with an emphasis on salient histologic, immunophenotypic, and genetic features.
    MeSH term(s) Cell Transformation, Neoplastic/pathology ; Diagnosis, Differential ; Disease Progression ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Lymphoma, Follicular/diagnosis ; Lymphoma, Follicular/pathology ; Lymphoma, Large B-Cell, Diffuse/pathology ; Neoplasm Grading
    Language English
    Publishing date 2016-03
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 1875-9157
    ISSN (online) 1875-9157
    DOI 10.1016/j.path.2015.09.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Pathology consultation on intermediate-to-large B-cell lymphomas.

    Montgomery, Nathan D / Fedoriw, Yuri

    American journal of clinical pathology

    2014  Volume 141, Issue 3, Page(s) 305–317

    Abstract: Objectives: Intermediate-to-large B-cell lymphomas represent a heterogeneous group of aggressive lesions frequently encountered in practice. The differential diagnosis includes the most common of all lymphomas, diffuse large B-cell lymphoma (DLBCL), as ... ...

    Abstract Objectives: Intermediate-to-large B-cell lymphomas represent a heterogeneous group of aggressive lesions frequently encountered in practice. The differential diagnosis includes the most common of all lymphomas, diffuse large B-cell lymphoma (DLBCL), as well as Burkitt lymphoma (BL), B-lymphoblastic lymphoma, and the blastoid variant of mantle cell lymphoma. In recent decades, gene expression profiling studies have clarified the biologic origins and features of these diseases. Moreover, clinically relevant subtypes of DLBCL have been identified, and a new category was defined: B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and BL. Herein, we review the salient diagnostic features of the various entities within this differential diagnosis and provide a stepwise diagnostic approach for dealing with challenging cases.
    Methods: A case-based approach is used to highlight diagnostic dilemmas and clinical decision points within the differential diagnosis of intermediate-to-large B-cell lymphomas.
    Results: Based on the published literature and World Health Organization criteria, we suggest a diagnostic algorithm for appropriate classification of these lymphomas.
    Conclusions: Correct classification of intermediate-to-large B-cell lymphomas is important, because prognosis and therapeutic approach vary for different tumors and tumor subclasses. Understanding both disease-specific criteria and pathologic features that influence clinical behavior within a category is imperative for evaluation of these lymphomas.
    MeSH term(s) Adolescent ; Aged ; Aged, 80 and over ; Diagnosis, Differential ; Gene Expression Profiling ; Genes, myc ; Humans ; In Situ Hybridization, Fluorescence ; Lymphoma, B-Cell/diagnosis ; Lymphoma, B-Cell/pathology ; Male ; Prognosis
    Language English
    Publishing date 2014-03
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 2944-0
    ISSN 1943-7722 ; 0002-9173
    ISSN (online) 1943-7722
    ISSN 0002-9173
    DOI 10.1309/AJCP3CP6VFZJYMTK
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.

    Blatt, Julie / Parekh, Preeti / Powell, Bradford C / Fedoriw, Yuri / Reddy, Indira / Montgomery, Nathan D

    Journal of pediatric hematology/oncology

    2020  Volume 43, Issue 5, Page(s) e689–e691

    Abstract: Rosai-Dorfman disease (RDD) typically presents as bulky lymphadenopathy. Somatic mutations in RAS/MAP kinase pathway genes are common but germline mutations are rare. A patient with RDD and exocrine pancreatic insufficiency was found to have a homozygous ...

    Abstract Rosai-Dorfman disease (RDD) typically presents as bulky lymphadenopathy. Somatic mutations in RAS/MAP kinase pathway genes are common but germline mutations are rare. A patient with RDD and exocrine pancreatic insufficiency was found to have a homozygous germline mutation in SLC29A3, which has been associated with the Histiocytosis/Lymphadenopathy Plus Syndrome. His RDD also was positive for a somatic mutation in lymphoid enhancer binding factor 1 (LEF1). The concurrence of RDD and pancreatic insufficiency should raise consideration of SLC29A3 mutations. Other cases will be needed to confirm this observation and a possible contribution of LEF1 to the development of RDD.
    MeSH term(s) Adult ; Exocrine Pancreatic Insufficiency/complications ; Exocrine Pancreatic Insufficiency/genetics ; Germ-Line Mutation ; Histiocytosis, Sinus/complications ; Histiocytosis, Sinus/genetics ; Humans ; Male ; Nucleoside Transport Proteins/genetics ; Young Adult
    Chemical Substances Nucleoside Transport Proteins ; SLC29A3 protein, human
    Language English
    Publishing date 2020-07-10
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 1231152-2
    ISSN 1536-3678 ; 1077-4114 ; 0192-8562
    ISSN (online) 1536-3678
    ISSN 1077-4114 ; 0192-8562
    DOI 10.1097/MPH.0000000000001889
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.

    Johnson, Steven M / Haberberger, James / Galeotti, Jonathan / Ramkissoon, Lori / Coombs, Catherine C / Richardson, Daniel R / Foster, Matthew C / Duncan, Daniel / Zeidner, Joshua F / Ferguson, Naomi L / Montgomery, Nathan D

    Blood cancer journal

    2023  Volume 13, Issue 1, Page(s) 96

    MeSH term(s) Humans ; Chromosomal Proteins, Non-Histone/genetics ; Cell Cycle Proteins/genetics ; Mutation ; Leukemia, Myeloid, Acute/genetics ; Repressor Proteins/genetics ; Cohesins
    Chemical Substances Chromosomal Proteins, Non-Histone ; Cell Cycle Proteins ; ASXL1 protein, human ; Repressor Proteins
    Language English
    Publishing date 2023-06-26
    Publishing country United States
    Document type Letter
    ZDB-ID 2600560-8
    ISSN 2044-5385 ; 2044-5385
    ISSN (online) 2044-5385
    ISSN 2044-5385
    DOI 10.1038/s41408-023-00876-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top